Goldman Sachs analysts removed Abbott (ABT) from the firm’s US Conviction List as part of its monthly update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 4/30/2026
- FDA releases results from ‘largest-ever’ testing of infant formula in the U.S.
- Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 4/29/2026
- Abbott receives FDA clearance and CE Mark for Ultreon imaging platform
- Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 4/28/2026